Scarica l'app Stockscreener
61.61
0.06%
0.0411
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DXCM Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$61.57
Aprire:
$61.12
Volume 24 ore:
849.21K
Relative Volume:
0.19
Capitalizzazione di mercato:
$23.79B
Reddito:
$4.66B
Utile/perdita netta:
$836.30M
Rapporto P/E:
29.44
EPS:
2.093
Flusso di cassa netto:
$1.08B
1 W Prestazione:
-4.66%
1M Prestazione:
-1.03%
6M Prestazione:
-12.77%
1 anno Prestazione:
-14.02%
Intervallo 1D:
$61.04
$62.08
Intervallo di 1 settimana:
$60.34
$65.00
Portata 52W:
$54.11
$89.98
Dexcom Inc Stock (DXCM) Company Profile
Nome
Dexcom Inc
Settore
Industria
Telefono
(858) 200-0200
Indirizzo
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Compare DXCM vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
61.65 | 23.76B | 4.66B | 836.30M | 1.08B | 2.093 |
ABT
Abbott Laboratories
|
93.14 | 158.35B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
327.99 | 125.43B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
83.30 | 106.97B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
61.13 | 92.25B | 20.62B | 3.56B | 3.66B | 2.3847 |
EW
Edwards Lifesciences Corp
|
84.42 | 48.52B | 6.30B | 1.07B | 1.34B | 1.8406 |
Dexcom Inc Stock (DXCM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-24 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2026-01-12 | Downgrade | Barclays | Equal Weight → Underweight |
| 2025-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2025-11-25 | Iniziato | Evercore ISI | In-line |
| 2025-10-21 | Ripresa | Stifel | Buy |
| 2025-09-08 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-08-21 | Iniziato | Argus | Buy |
| 2025-06-16 | Iniziato | Truist | Buy |
| 2025-05-30 | Iniziato | Goldman | Buy |
| 2025-04-10 | Iniziato | Mizuho | Outperform |
| 2025-02-03 | Aggiornamento | Redburn Atlantic | Neutral → Buy |
| 2025-01-16 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-07-26 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-07-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | Iniziato | Redburn Atlantic | Neutral |
| 2024-03-12 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-04-17 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2023-01-26 | Iniziato | Wolfe Research | Outperform |
| 2022-10-18 | Iniziato | Barclays | Equal Weight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-15 | Iniziato | Bernstein | Outperform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-03 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-01-19 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2021-10-18 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-07-21 | Ripresa | Cowen | Outperform |
| 2021-05-28 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2021-01-06 | Aggiornamento | UBS | Neutral → Buy |
| 2020-10-02 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | Reiterato | Piper Sandler | Overweight |
| 2020-05-14 | Iniziato | Wells Fargo | Equal Weight |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2019-11-07 | Reiterato | Canaccord Genuity | Buy |
| 2019-11-07 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-10-23 | Iniziato | Stifel | Buy |
| 2018-11-28 | Iniziato | UBS | Neutral |
| 2018-10-19 | Aggiornamento | Goldman | Sell → Neutral |
| 2018-09-12 | Aggiornamento | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | Reiterato | Canaccord Genuity | Buy |
| 2018-07-02 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-05-11 | Iniziato | BofA/Merrill | Buy |
| 2018-05-03 | Reiterato | Canaccord Genuity | Buy |
| 2018-04-04 | Iniziato | Goldman | Sell |
| 2018-04-04 | Iniziato | Guggenheim | Neutral |
| 2018-03-23 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | Downgrade | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | Reiterato | Wedbush | Outperform |
Mostra tutto
Dexcom Inc Borsa (DXCM) Ultime notizie
Is DexCom, Inc. (DXCM) A Good Stock To Buy Now? - Insider Monkey
Teacher Retirement System of Texas Has $11.04 Million Position in DexCom, Inc. $DXCM - MarketBeat
M&T Bank Corp Has $6.28 Million Holdings in DexCom, Inc. $DXCM - MarketBeat
DexCom Inc. stock underperforms Friday when compared to competitors - MarketWatch
BTIG Maintains DexCom (DXCM) Buy Recommendation - MSN
DEXCOM INC (NASDAQ:DXCM) Shows Strong Fundamentals and a Promising Technical Breakout Setup - ChartMill
DexCom Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Peregrine Capital Management LLC Raises Position in DexCom, Inc. $DXCM - MarketBeat
Forget Ozempic: This High‑Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins - The Motley Fool
Cwm LLC Sells 91,609 Shares of DexCom, Inc. $DXCM - MarketBeat
DexCom’s quarterly earnings preview: What you need to know - MSN
DexCom Inc. (DXCM)Valuation Disparity Widens Amid Short-Term Price Weakness And Long-Term Growth Catalysts - Cổng thông tin điện tử tỉnh Lào Cai
A Look at DexCom Inc (DXCM) After 3.1% Decline -- GF Value $109. - GuruFocus
DexCom Stock Hits Day Low of $62 Amid Price Pressure - Markets Mojo
DexCom Inc. stock outperforms competitors despite losses on the day - MarketWatch
State Street Premier Growth Equity V.I.S. Fund's DexCom Inc(DXCM) Holding History - GuruFocus
A Look At Dexcom (DXCM) Valuation As Shares Lag And Fair Value Estimates Point Higher - Yahoo Finance
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
Better Medical Device Stock Right Now: Abbott Laboratories vs. Dexcom - Yahoo Finance
Devon Energy Corp stock (US2521311074): Why Google Discover changes matter more now - AD HOC NEWS
DexCom, Inc. (DXCM) Stock Analysis: Strong Buy Ratings And A 35.78% Potential Upside - DirectorsTalk Interviews
DexCom Projected to Grow Profits as Q1 2026 Earnings Date Approaches - HarianBasis.co
Dexcom Inc. stock (US2521311074): Is continuous glucose monitoring strong enough to unlock new upsid - AD HOC NEWS
Lecap Asset Management Ltd. Acquires New Position in DexCom, Inc. $DXCM - MarketBeat
DexCom’s Quarterly Earnings Preview: What You Need to Know - Barchart
Devon Energy Corp stock (US2521311074): Is its shale production edge strong enough to unlock new ups - AD HOC NEWS
Lobbying Update: $75,000 of DEXCOM lobbying was just disclosed - Quiver Quantitative
TWIN CITY PRIVATE WEALTH, LLC's DexCom Inc(DXCM) Holding History - GuruFocus
DexCom, Inc. $DXCM Shares Purchased by Moran Wealth Management LLC - MarketBeat
KBC Group NV Sells 133,500 Shares of DexCom, Inc. $DXCM - MarketBeat
Chicago Capital LLC Reduces Position in DexCom, Inc. $DXCM - MarketBeat
DexCom, Inc. $DXCM Shares Purchased by Assetmark Inc. - MarketBeat
TransMedics & Dexcom: Healthcare Stocks for Long-Term GrowthNews and Statistics - IndexBox
A Look at DexCom Inc (DXCM) After 4.5% Gain -- GF Value $109.11 vs Price $63.98 - GuruFocus
Dexcom EVP Brown sells $107k in shares By Investing.com - Investing.com South Africa
Dexcom EVP Brown sells $107k in shares - Investing.com
Dexcom (DXCM) EVP sells 1,700 shares, still holds 111,204 - Stock Titan
Here's Why You Should Add DexCom Stock to Your Portfolio Now - Yahoo Finance
DexCom, Inc. $DXCM Shares Sold by Robeco Institutional Asset Management B.V. - MarketBeat
DXCM | DexCom, Inc. Executive Compensation - Quiver Quantitative
DexCom down 6% as post Q2 earnings release slump continues - MSN
3 Reasons Investors Love DexCom (DXCM) - Barchart
DEXCOM INC ($DXCM) President & CEO 2025 Pay Revealed - Quiver Quantitative
DexCom Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DexCom | ARS: Annual Report to Security Holders - Moomoo
[ARS] DEXCOM INC SEC Filing - Stock Titan
Dexcom (NASDAQ: DXCM) posts growth, seeks votes on board, pay and auditor - Stock Titan
Michael Brown (DXCM) files Form 144 to sell 1,700 restricted shares - Stock Titan
DexCom (DXCM) Upgraded to Buy: Here's Why - Yahoo Finance
Sumitomo Mitsui Trust Group Inc. Sells 15,977 Shares of DexCom, Inc. $DXCM - MarketBeat
DexCom, Inc. $DXCM Shares Sold by Massachusetts Financial Services Co. MA - MarketBeat
Dexcom Inc Azioni (DXCM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):